Despite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges wi...

As the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...

Enforcement Directorate has arrested Harpreet Singh Talwar, a key figure in a money laundering probe linked to a massive heroin seizure at ...

India's drug regulator is intensifying border screenings to block unapproved medicines from entering the country. Authorities are cracking ...

India is set to implement a mandatory registration for printed pharmaceutical packaging manufacturers to combat counterfeit drugs. This mov...

Indian stainless steel MSMEs are urging the government to reinstate a quality control order after its suspension led to a surge in cheap Ch...

Indian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...

India's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...

India's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...

Government's Minimum Import Price (MIP) initiative to boost domestic drug makers faces a slow start. Despite setting price thresholds for k...

Health officials revealed that in May 2026, 46 drug samples tested by Central Drugs Laboratories and 113 by State Drugs Testing Laboratorie...

DEA agents in New Mexico allegedly allowed hundreds of thousands of fentanyl pills onto streets between 2023-2025, prioritizing larger case...

Fixed dose combination banned full list: India has banned 16 fixed-dose combination drugs, including certain antibiotics and antispasmodics...

In a significant public health initiative, the ban on 16 fixed-dose drug combinations, including various antibiotics and topical formulatio...

India's drug regulator is proposing to allow hospitals to directly import advanced medical equipment like MRI and CT scanners, bypassing cu...

Even in small villages with a population of less than 1,000, where certain remedies including cough syrups were allowed to be sold without ...

Indian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...